In last trading session, AN2 Therapeutics Inc (NASDAQ:ANTX) saw 0.43 million shares changing hands with its beta currently measuring -0.18. Company’s recent per share price
During the last session, AN2 Therapeutics Inc (NASDAQ:ANTX)’s traded shares were 1.02 million, with the beta value of the company hitting -0.18. At the end
In today’s recent session, 0.42 million shares of the AN2 Therapeutics Inc (NASDAQ:ANTX) have been traded, and its beta is -0.20. Most recently the company’s
AN2 Therapeutics Inc (NASDAQ:ANTX)’s traded shares stood at 1.76 million during the last session, with the company’s beta value hitting -0.15. At the close of
In the last trading session, 1.57 million AN2 Therapeutics Inc (NASDAQ:ANTX) shares changed hands as the company’s beta touched -0.09. With the company’s per share
In the last trading session, 1.91 million AN2 Therapeutics Inc (NASDAQ:ANTX) shares changed hands as the company’s beta touched -0.08. With the company’s per share
In last trading session, AN2 Therapeutics Inc (NASDAQ:ANTX) saw 2.83 million shares changing hands with its beta currently measuring 0.04. Company’s recent per share price
AN2 Therapeutics Inc (NASDAQ:ANTX) has a beta value of 0.19 and has seen 1.45 million shares traded in the last trading session. The ANTX stock
AN2 Therapeutics Inc (NASDAQ:ANTX) has a beta value of -0.12 and has seen 11.79 million shares traded in the last trading session. The company, currently
During the recent session, AN2 Therapeutics Inc (NASDAQ:ANTX)’s traded shares were 6.2 million, with the beta value of the company hitting -0.12. At the last
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
